Study
Prescription of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for the Prophylaxis of Migraine in Austria: A Retrospective, Longitudinal Analysis of Nationwide Insurance Data
This large Austrian insurance-based study found that monoclonal antibodies targeting CGRP significantly reduced migraine frequency and health care ...
Summary
In plain language
This large Austrian insurance-based study found that monoclonal antibodies targeting CGRP significantly reduced migraine frequency and health care use. Benefits were consistent across age groups, including adults over 60.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
A nationwide analysis in Austria found that patients treated with CGRP monoclonal antibodies experienced fewer migraine days and hospitalizations, confirming the safety and effectiveness of this therapy for migraine prevention.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Prescription of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for the Prophylaxis of Migraine in Austria: A Retrospective, Longitudinal Analysis of Nationwide Insurance Data
Published December 2025
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored February 1, 2026 using rubric v6_2026-02-01.
Assessment
The study provides useful insights into the use of monoclonal antibodies for migraine prevention in older adults, but its retrospective design and potential biases limit the strength of its conclusions. It is relevant to seniors but should be interpreted with caution due to methodological limitations.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 5.0/10 | |
| Bias control | 4.0/10 | |
| Statistical methods | 6.0/10 | |
| Reporting completeness | 7.0/10 | |
| Conflicts & funding | 8.0/10 | |
| Replication | 5.0/10 | |
| Relevance to chosen population | 7.0/10 | |
| Journal Reliability | 8.0/10 |
Additional Notes
Future studies should aim for prospective designs with clear bias control methods to strengthen evidence quality.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.